These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 21720247

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).
    Sinclair A, Appel G, Dooley MA, Ginzler E, Isenberg D, Jayne D, Wofsy D, Solomons N.
    Lupus; 2007; 16(12):972-80. PubMed ID: 18042591
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A.
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil for lupus nephritis: an update.
    Mok CC.
    Expert Rev Clin Immunol; 2015 Jul; 11(12):1353-64. PubMed ID: 26364748
    [Abstract] [Full Text] [Related]

  • 7. The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis.
    Wilson EC, Jayne DR, Dellow E, Fordham RJ.
    Rheumatology (Oxford); 2007 Jul; 46(7):1096-101. PubMed ID: 17409128
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H.
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Mar; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
    Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N, ALMS Group.
    N Engl J Med; 2011 Nov 17; 365(20):1886-95. PubMed ID: 22087680
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study.
    Walsh M, Solomons N, Lisk L, Jayne DR.
    Am J Kidney Dis; 2013 May 17; 61(5):710-5. PubMed ID: 23375819
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    Tselios K, Gladman DD, Su J, Urowitz MB.
    J Rheumatol; 2016 Mar 17; 43(3):552-8. PubMed ID: 26773121
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U, Bauer H, Märker-Hermann E.
    Dtsch Med Wochenschr; 2006 Oct 13; 131(41):2266-9. PubMed ID: 17036267
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Statement on the use of mycophenolate mofetil for systemic lupus erythematosus].
    Aringer M, Fischer-Betz R, Hiepe F, Kommission Pharmakotherapie der DGRh, Germany Society of Rheumatology.
    Z Rheumatol; 2013 Aug 13; 72(6):575-80. PubMed ID: 23756593
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.
    J Rheumatol; 2015 Nov 13; 42(11):2082-91. PubMed ID: 26373566
    [Abstract] [Full Text] [Related]

  • 20. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan 13; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.